ADCBiologicstaleDaiichi SankyoPhase 3
trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Megestrol Acetate + Trastuzumab Deruxtecan)
Advanced/Metastatic Breast Cancer; HER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer · HER2
#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 RECRUITING